Search - tctmd.com

Displaying 241 - 260 of 2970

Sort: Relevancy | Date

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2022

Caitlin E. Cox

April 01, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Daily News

No Stents in STEMI? With Careful Selection, Maybe

Caitlin E. Cox

March 21, 2022

News Features

Bloodlines: How Far Should Cardiologists Go in Treating Family?

Todd Neale

March 10, 2022

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Caitlin E. Cox

March 02, 2022

Presentation CTO 2022

What to Do When Stents Fail: How to Assess and Treat

Presenter: Jennifer Tremmel

February 25, 2022

News Conference News ISC 2022

Endovascular Stroke Therapy Works for Large Infarcts: RESCUE-Japan LIMIT

Todd Neale

February 09, 2022

News Conference News STS 2022

Decades of Real-world Data Affirm Benefit of Multiple Arterial CABG

Yael L. Maxwell

February 03, 2022

News Daily News

Lower Costs for TAVI Valves Could Improve Access, Analysis Hints

Yael L. Maxwell

January 24, 2022

News Daily News

Heavy Calcification Levels PCI/CABG Playing Field at 10 Years: SYNTAXES

Yael L. Maxwell

January 06, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

Presentation TCT 2021

TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes

Presenter: Pasi Karjalainen

November 06, 2021

Presentation TCT 2021

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

Presenter: IN-HO CHAE

November 06, 2021

Presentation TCT 2021

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

Presenter: Eline Ploumen

November 06, 2021

News Conference News TCT 2021

DCBs in Coronaries? Some Good News, but More Work Needed

L.A. McKeown

November 06, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

Advertisement

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

TCTMD’s Top 10 Most Popular Stories for March 2022

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

No Stents in STEMI? With Careful Selection, Maybe

Bloodlines: How Far Should Cardiologists Go in Treating Family?

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

What to Do When Stents Fail: How to Assess and Treat

Endovascular Stroke Therapy Works for Large Infarcts: RESCUE-Japan LIMIT

Decades of Real-world Data Affirm Benefit of Multiple Arterial CABG

Lower Costs for TAVI Valves Could Improve Access, Analysis Hints

Heavy Calcification Levels PCI/CABG Playing Field at 10 Years: SYNTAXES

January 2022 News Roundup

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

DCBs in Coronaries? Some Good News, but More Work Needed

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content